CLDI - Calidi Biotherapeutics, Inc.
0.4589
0.044 9.566%
Share volume: 114,346
Last Updated: 05-09-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$0.42
0.04
0.11%
Summary score
15%
Profitability
0%
Dept financing
25%
Liquidity
1%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-51.02%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
199.18%
Debt ratio change over timeo
0%
Current Ratio
0.11%
Quick Ratio
0%
Cash Position Ratio
0.08%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-63.85%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
226.16%
Debt ratio change over timeo
0%
Current Ratio
0.14%
Quick Ratio
0%
Cash Position Ratio
0.11%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-91.18%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
296.8%
Debt ratio change over time
0%
Current Ratio
0.13%
Quick Ratio
0%
Cash Position Ratio
0.08%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CLDI | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | 0% | 18.15% | 4.7% | 14.29% |
| Return on assets | -51.02% | 3.24% | 3.2% | 13.62% |
| Return on sales | 0% | 32.46% | 30.7% | -6.59% |
| Return on invested capital | 0% | 5.53% | 2.12% | -56.74% |
| Profitability | 0% | 81% | 46% | 45% |
| Total debt ratio | 199.18% | 90.54% | 68.11% | 22.02% |
| Debt ratio change over time | 0% | 20.48% | 112.19% | -1.07% |
| Dept financing | 25% | 16% | 34% | 3% |
| Current Ratio | 0.14% | 2.18% | 1.22% | 10.44% |
| Quick Ratio | 0% | 1.79% | 1.08% | 10.22% |
| Cash Position Ratio | 0.11% | 1.28% | 0.51% | 6.62% |
| Liquididy | 1% | 20% | 16% | 75% |
| Short-term ratios | CLDI | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 6.99% | 0.15% |
| Return on assets | -63.85% | 2.04% | 0.78% | -0.42% |
| Return on sales | 0% | 24.13% | 7.73% | -132.4% |
| Return on invested capital | 0% | 0% | 4.5% | 3.44% |
| Profitability | 0% | 50% | 68% | 20% |
| Total debt ratio | 226.16% | 93.05% | 65.59% | 10.81% |
| Debt ratio change over time | 0% | 0% | 17.12% | -0.76% |
| Dept financing | 25% | 10% | 32% | 1% |
| Current Ratio | 0.14% | 2.18% | 1.22% | 10.44% |
| Quick Ratio | 0% | 1.79% | 1.08% | 10.22% |
| Cash Position Ratio | 0.11% | 1.28% | 0.51% | 6.62% |
| Liquididy | 1% | 14% | 7% | 75% |
